| - GRCh37:
- Chr22:42322318
- GRCh38:
- Chr22:41926314
| LOC130067574, TNFRSF13C | A52T | Immunodeficiency, common variable, 4 | Likely pathogenic (Dec 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322739
- GRCh38:
- Chr22:41926735
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322177
- GRCh38:
- Chr22:41926173
| LOC130067574, TNFRSF13C | V99L | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322241
- GRCh38:
- Chr22:41926237
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322756
- GRCh38:
- Chr22:41926752
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321422
- GRCh38:
- Chr22:41925418
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322247
- GRCh38:
- Chr22:41926243
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322677
- GRCh38:
- Chr22:41926673
| LOC130067574, TNFRSF13C | A34V | Immunodeficiency, common variable, 4 | Uncertain significance (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321404
- GRCh38:
- Chr22:41925400
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322763
- GRCh38:
- Chr22:41926759
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322115
- GRCh38:
- Chr22:41926111
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jan 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321481
- GRCh38:
- Chr22:41925477
| TNFRSF13C | G149R | Immunodeficiency, common variable, 4 | Uncertain significance (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322767
- GRCh38:
- Chr22:41926763
| LOC130067574, TNFRSF13C | G4A | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322697
- GRCh38:
- Chr22:41926693
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321414
- GRCh38:
- Chr22:41925410
| TNFRSF13C | T171S | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322184
- GRCh38:
- Chr22:41926180
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321415
- GRCh38:
- Chr22:41925411
| TNFRSF13C | T171S | Immunodeficiency, common variable, 4 | Uncertain significance (Apr 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322273
- GRCh38:
- Chr22:41926269
| LOC130067574, TNFRSF13C | A67S | Immunodeficiency, common variable, 4 | Uncertain significance (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322298
- GRCh38:
- Chr22:41926294
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322625
- GRCh38:
- Chr22:41926621
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322277
- GRCh38:
- Chr22:41926273
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Dec 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321389
- GRCh38:
- Chr22:41925385
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321571
- GRCh38:
- Chr22:41925567
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322112
- GRCh38:
- Chr22:41926108
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Nov 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322658
- GRCh38:
- Chr22:41926654
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Mar 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321389
- GRCh38:
- Chr22:41925385
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322091
- GRCh38:
- Chr22:41926087
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322751
- GRCh38:
- Chr22:41926747
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322087
- GRCh38:
- Chr22:41926083
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Benign (May 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322295
- GRCh38:
- Chr22:41926291
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322727
- GRCh38:
- Chr22:41926723
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Nov 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321502
- GRCh38:
- Chr22:41925498
| TNFRSF13C | A142T | Immunodeficiency, common variable, 4 | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322776
- GRCh38:
- Chr22:41926772
| LOC130067574, TNFRSF13C | M1K | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322650
- GRCh38:
- Chr22:41926646
| LOC130067574, TNFRSF13C | P43L | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322677
- GRCh38:
- Chr22:41926673
| LOC130067574, TNFRSF13C | A34D | Immunodeficiency, common variable, 4 | Uncertain significance (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321534
- GRCh38:
- Chr22:41925530
| TNFRSF13C | I131T | Immunodeficiency, common variable, 4 | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321493
- GRCh38:
- Chr22:41925489
| TNFRSF13C | W145R | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321474
- GRCh38:
- Chr22:41925470
| TNFRSF13C | D151V | Immunodeficiency, common variable, 4 | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322263
- GRCh38:
- Chr22:41926259
| LOC130067574, TNFRSF13C | A70V | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322227
- GRCh38:
- Chr22:41926223
| LOC130067574, TNFRSF13C | P82L | Immunodeficiency, common variable, 4 | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322140-42322141
- GRCh38:
- Chr22:41926136-41926137
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321429
- GRCh38:
- Chr22:41925425
| TNFRSF13C | T166I | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322234
- GRCh38:
- Chr22:41926230
| LOC130067574, TNFRSF13C | G80S | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321495
- GRCh38:
- Chr22:41925491
| TNFRSF13C | A144V | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:41277754-43089957
| A4GALT, ACO2, ATP5MGL, CCDC134, CENPM, CHADL, CSDC2, CYB5R3, CYP2D6, DESI1, EP300, L3MBTL2, L3MBTL2-AS1, MEI1, MIR33A, NAGA, NDUFA6, NFAM1, PHETA2, PHF5A, PMM1, POLDIP3, POLR3H, RANGAP1, RBX1, RRP7A, SEPTIN3, SERHL2, SHISA8, SMDT1, SNU13, SREBF2, TCF20, TEF, TNFRSF13C, TOB2, WBP2NL, XPNPEP3, XRCC6, ZC3H7B | | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321523
- GRCh38:
- Chr22:41925519
| TNFRSF13C | P135S | Immunodeficiency, common variable, 4 | Uncertain significance (Oct 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322330
- GRCh38:
- Chr22:41926326
| LOC130067574, TNFRSF13C | A48T | Immunodeficiency, common variable, 4 | Uncertain significance (Oct 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321447
- GRCh38:
- Chr22:41925443
| TNFRSF13C | S160I | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322743
- GRCh38:
- Chr22:41926739
| LOC130067574, TNFRSF13C | D12G | Immunodeficiency, common variable, 4 | Uncertain significance (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322185-42322186
- GRCh38:
- Chr22:41926181-41926182
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322105
- GRCh38:
- Chr22:41926101
| TNFRSF13C | A123T | Immunodeficiency, common variable, 4 | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322764
- GRCh38:
- Chr22:41926760
| LOC130067574, TNFRSF13C | P5H | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322644
- GRCh38:
- Chr22:41926640
| TNFRSF13C, LOC130067574 | P45L | Immunodeficiency, common variable, 4 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322141
- GRCh38:
- Chr22:41926137
| LOC130067574, TNFRSF13C | A111S | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322652
- GRCh38:
- Chr22:41926648
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jul 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321419
- GRCh38:
- Chr22:41925415
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Feb 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322232
- GRCh38:
- Chr22:41926228
| TNFRSF13C, LOC130067574 | | Immunodeficiency, common variable, 4 | Likely benign (May 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322745
- GRCh38:
- Chr22:41926741
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Aug 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322196
- GRCh38:
- Chr22:41926192
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322089
- GRCh38:
- Chr22:41926085
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321568
- GRCh38:
- Chr22:41925564
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321388
- GRCh38:
- Chr22:41925384
| TNFRSF13C | G180S | Immunodeficiency, common variable, 4 | Uncertain significance (Mar 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322246
- GRCh38:
- Chr22:41926242
| LOC130067574, TNFRSF13C | G76W | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322767
- GRCh38:
- Chr22:41926763
| LOC130067574, TNFRSF13C | G4E | Immunodeficiency, common variable, 4 | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322207-42322208
- GRCh38:
- Chr22:41926203-41926204
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322248
- GRCh38:
- Chr22:41926244
| LOC130067574, TNFRSF13C | P75H | Immunodeficiency, common variable, 4 | Uncertain significance (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322186-42322197
- GRCh38:
- Chr22:41926182-41926193
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322689
- GRCh38:
- Chr22:41926685
| LOC130067574, TNFRSF13C | R30H | Immunodeficiency, common variable, 4 | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322196-42322197
- GRCh38:
- Chr22:41926192-41926193
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322204-42322215
- GRCh38:
- Chr22:41926200-41926211
| TNFRSF13C, LOC130067574 | | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322741
- GRCh38:
- Chr22:41926737
| LOC130067574, TNFRSF13C | A13S | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321571
- GRCh38:
- Chr22:41925567
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42321264
- GRCh38:
- Chr22:41925260
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321118
- GRCh38:
- Chr22:41925114
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322165
- GRCh38:
- Chr22:41926161
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Conflicting interpretations of pathogenicity (Nov 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42322128
- GRCh38:
- Chr22:41926124
| TNFRSF13C | E115V | Immunodeficiency, common variable, 4 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321573
- GRCh38:
- Chr22:41925569
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Conflicting interpretations of pathogenicity (Oct 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42322282
- GRCh38:
- Chr22:41926278
| LOC130067574, TNFRSF13C | G64S | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322150-42322161
- GRCh38:
- Chr22:41926146-41926157
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322194
- GRCh38:
- Chr22:41926190
| TNFRSF13C, LOC130067574 | L93P | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322273
- GRCh38:
- Chr22:41926269
| TNFRSF13C, LOC130067574 | A67T | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321351-42322797
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Uncertain significance (Jul 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322121
- GRCh38:
- Chr22:41926117
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322676
- GRCh38:
- Chr22:41926672
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42322226
- GRCh38:
- Chr22:41926222
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Conflicting interpretations of pathogenicity (Aug 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42322696
- GRCh38:
- Chr22:41926692
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Nov 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321479
- GRCh38:
- Chr22:41925475
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321521
- GRCh38:
- Chr22:41925517
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Aug 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321551
- GRCh38:
- Chr22:41925547
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42321490
- GRCh38:
- Chr22:41925486
| TNFRSF13C | P146S | Immunodeficiency, common variable, 4 | Conflicting interpretations of pathogenicity (Oct 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42321383-42321392
- GRCh38:
- Chr22:41925379-41925388
| TNFRSF13C | A179fs | Immunodeficiency, common variable, 4 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321441
- GRCh38:
- Chr22:41925437
| TNFRSF13C | P162L | Immunodeficiency, common variable, 4 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322147
- GRCh38:
- Chr22:41926143
| LOC130067574, TNFRSF13C | R109C | Immunodeficiency, common variable, 4 | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322299
- GRCh38:
- Chr22:41926295
| LOC130067574, TNFRSF13C | Q58L | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42321448
- GRCh38:
- Chr22:41925444
| TNFRSF13C | S160G | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:41697339-42466321
- GRCh38:
- Chr22:41301335-42070317
| LOC125446244, LOC130067573, LOC130067574, LOC130067575, LOC130067580, LOC130067581, MEI1, MIR33A, MIR378I, NAGA, PHF5A, LOC130067578, LOC130067579, LOC126863159, LOC130067541, LOC130067542, LOC126863160, LOC130067543, LOC130067544, LOC130067545, LOC130067546, LOC130067547, LOC130067548, LOC130067537, LOC130067538, LOC130067539, LOC130067540, LOC130067576, LOC130067577, ACO2, CCDC134, CENPM, CSDC2, DESI1, LOC105373044, LOC108348030, LOC110740341, LOC111562373, LOC112695098, LOC121627945, LOC121627946, LOC130067549, LOC130067550, LOC130067551, LOC130067552, LOC130067553, LOC130067554, LOC130067555, LOC130067556, LOC130067557, LOC130067558, LOC130067559, LOC130067560, LOC130067561, LOC130067562, LOC130067563, LOC130067564, LOC130067565, LOC130067566, LOC130067567, LOC130067568, LOC130067569, LOC130067570, LOC130067571, LOC130067572, PMM1, POLR3H, RANGAP1, SEPTIN3, SHISA8, SMIM45, SNU13, SREBF2, SREBF2-AS1, TEF, TNFRSF13C, TOB2, WBP2NL, XRCC6, ZC3H7B | | Immunodeficiency, common variable, 4 | Uncertain significance (Aug 17, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322646
- GRCh38:
- Chr22:41926642
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Aug 7, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322259
- GRCh38:
- Chr22:41926255
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Conflicting interpretations of pathogenicity (Jul 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42322095
- GRCh38:
- Chr22:41926091
| TNFRSF13C | | Immunodeficiency, common variable, 4 | Likely benign (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42322190
- GRCh38:
- Chr22:41926186
| LOC130067574, TNFRSF13C | | Immunodeficiency, common variable, 4 | Benign/Likely benign (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |